Related Experiment Video
Updated: Feb 5, 2026

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass
Published on: May 27, 2022
Cannabis and cannabinoid drug development: evaluating botanical versus single molecule approaches
Marcel O Bonn-Miller1, Mahmoud A ElSohly2,3,4, Mallory J E Loflin5
1a Department of Psychiatry , University of Pennsylvania Perelman School of Medicine , Philadelphia , PA , USA.
Abstract:
Accumulating evidence suggests that the endocannabinoid system is a promising target for the treatment of a variety of health conditions. Two paths of cannabinoid drug development have emerged. One approach is focused on developing medications that are directly derived from the cannabis plant. The other utilizes a single molecule approach whereby individual phytocannabinoids or novel cannabinoids with therapeutic potential are identified and synthesized for pharmaceutical development. This commentary discusses the unique challenges and merits of botanical vs single molecule cannabinoid drug development strategies, highlights how both can be impacted by legalization of cannabis via legislative processes, and also addresses regulatory and public health considerations that are important to consider as cannabinoid medicine advances as a discipline.
Related Concept Videos
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Molecules and Compounds
In Vitro Drug Release Testing: Overview, Development and Validation
Frustration and Conflict: Approach-Approach, Approach-Avoidance
One common type of conflict is the Approach–Approach Conflict. In this case, a person faces two desirable...
Self-Evaluation: Self-Enhancement and Self-Verification

